Market Eyes LiveGH Research PLC (GHRS) Stock Rating
MELANY's data-driven read on GH Research PLC.
—
Live rating in app
···
Live price
GH Research PLC is a clinical-stage biopharmaceutical company developing a treatment for depression, initially focused on proprietary mebufotenin therapies for patients with Treatment-Resistant Depression (TRD). Its portfolio includes GH001, an inhalable mebufotenin candidate, and GH002, an intravenous mebufotenin candidate, and it operates in a single Research and Development segment.
Entry zone, stop-loss, price targets, and live alerts unlock when you sign up. No card required.